Stanford University Medical Center — Stanford, California

Public research footprint of Stanford University Medical Center, compiled from the ClinicalTrials.gov public registry.

490

Registered studies

Active

Recruiting now

326

Completed

Stopped or withdrawn

Most-studied conditions

Relapsed or Refractory Hodgkin Lymphoma · Atherosclerotic Cardiovascular Disease (ASCVD) · Chronic Lymphocytic Leukemia (CLL) · Multiple Sclerosis

Recently updated registry entries

NCT04658862 — A Study of TAR-200 in Combination With Cetrelimab Versus Concurrent Chemoradiotherapy in… (Active Not Recruiting)
NCT04557098 — A Study of Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma (Active Not Recruiting)
NCT07276399 — A Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared With SOC… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Stanford University Medical Center?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 03, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.